Drug targets for cognitive enhancement in neuropsychiatric disorders.

Long‐lasting potentiation of synaptic transmission in the dentate area of the unanaesthetized rabbit following stimulation of the perforant path

Bliss, T. V. P., & Gardner-Medwin, A. R. (1973) · The Journal of Physiology · doi:10.1113/jphysiol.1973.sp010274 · Cited by 7,460 · see citing works

A review of central 5-HT receptors and their function

Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,150 · see citing works

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · see citing works

Hypothalamic regulation of sleep and circadian rhythms

Saper, C. B., Scammell, T. E., & Lu, J. (2005) · Nature · doi:10.1038/nature04284 · Cited by 2,804 · see citing works

Genetic enhancement of learning and memory in mice

Tang, Y., Shimizu, E., Dubé, G., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,867 · see citing works

Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease

Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1× · see citing works

Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

Arrang, J., Garbarg, M., & Schwartz, J. (1983) · Nature · doi:10.1038/302832a0 · Cited by 1,584 · see citing works

The mGluR theory of fragile X mental retardation

Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · see citing works

Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium

Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471 · see citing works

Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS

Green, M. F., Kern, R. S., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.009 · Cited by 1,422 · see citing works

Fear conditioning induces associative long-term potentiation in the amygdala

Rogan, M. T., Stäubli, U. V., & LeDoux, J. E. (1997) · Nature · doi:10.1038/37601 · Cited by 1,310 · see citing works

GABA _A ‐receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits

Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244 · see citing works

Histamine in the Nervous System

Haas, H. L., Sergeeva, O. A., & Selbach, O. (2008) · Physiological Reviews · doi:10.1152/physrev.00043.2007 · Cited by 1,227 · see citing works

Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172 · see citing works

Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats

Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006 · see citing works

Correction of Fragile X Syndrome in Mice

Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · see citing works

Molecular and neuronal substrate for the selective attenuation of anxiety

Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946 · see citing works

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944 · see citing works

Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

Levey, A. I., Kitt, C. A., Wf, S., Price, D., & Brann, M. R. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-10-03218.1991 · Cited by 920 · see citing works

Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors

Cartmell, J., & Schoepp, D. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750889.x · Cited by 883 · see citing works

Brain nicotinic acetylcholine receptors: native subtypes and their relevance

Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882 · see citing works

Ionotropic and metabotropic glutamate receptor structure and pharmacology

Kew, J. N. C., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2200-z · Cited by 792 · see citing works

Metabotropic glutamate receptors: electrophysiological properties and role in plasticity

Anwyl, R. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00050-2 · Cited by 776 · see citing works

Fear conditioning induces a lasting potentiation of synaptic currents in vitro

McKernan, M. G., & Shinnick-Gallagher, P. (1997) · Nature · doi:10.1038/37605 · Cited by 771 · see citing works

D-Alanine Added to Antipsychotics for the Treatment of Schizophrenia

Tsai, G. E., Yang, P., Chang, Y., & Chong, M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.032 · Cited by 676 · see citing works

Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain

Romano, C., Sesma, M. A., McDonald, C. T., O’Malley, K. L., van den Pol, A. N., & Olney, J. W. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903550310 · Cited by 671 · see citing works

Neuronal Correlates of Habituation and Dishabituation of the Gill-Withdrawal Reflex in Aplysia

Kupfermann, I., Castellucci, V. F., Pinsker, H. M., & Kandel, E. R. (1970) · Science · doi:10.1126/science.167.3926.1743 · Cited by 658 · see citing works

Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: An in situ hybridization study in adult and developing rat

Shigemoto, R., Nakanishi, S., & Mizuno, N. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903220110 · Cited by 644 · see citing works

Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development

Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637 · see citing works

SEVERE ANXIETY INDUCED BY FG 7142, A β-CARBOLINE LIGAND FOR BENZODIAZEPINE RECEPTORS

Dorow, R., Horowski, R., Paschelke, G., Amin, M., & Bræstrup, C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90076-4 · Cited by 580 · see citing works

D-serine added to antipsychotics for the treatment of schizophrenia

Tsai, G. E., Yang, P., Chung, L.-C., LANGE, N. D., & Coyle, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00279-0 · Cited by 572 · see citing works

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys

Arnsten, A. F. T., Cai, J. X., Murphy, B. L., & Goldman-Rakic, P. S. (1994) · Psychopharmacology · doi:10.1007/bf02245056 · Cited by 566 · see citing works

Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat

Ohishi, H., Shigemoto, R., Nakanishi, S., & Mizuno, N. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90485-x · Cited by 560 · see citing works

Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors

Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558 · see citing works

Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro.

Andrade, R., & Nicoll, R. A. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016862 · Cited by 552 · see citing works

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

Goldman-Rakic, P., Castner, S., Svensson, T., Siever, L., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1793-y · Cited by 544 · see citing works

Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia

D, A. O. M., Harris, J. G., Johnson, L. L., Pender, V., Kongs, S., Allensworth, D., Ellis, J., Zerbe, G. O., Leonard, S. S., Stevens, K. E., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.630 · Cited by 531 · see citing works

Trace fear conditioning involves hippocampal α ₅ GABA _A receptors

Crestani, F., Keist, R., Fritschy, J.-M., Benke, D., Vogt, K., Prut, L., Blüthmann, H., Möhler, H., & Rudolph, U. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142288699 · Cited by 528 · see citing works

Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain

Shigemoto, R., Nomura, S., Ohishi, H., Sugihara, H., Nakanishi, S., & Mizuno, N. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90227-c · Cited by 521 · see citing works

Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome

Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., & Garner, C. C. (2007) · Nature Neuroscience · doi:10.1038/nn1860 · Cited by 509 · see citing works

Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks

Venault, P., Chapouthier, G., de Carvalho, L. P., Simiand, J., Morre, M., Dodd, R. H., & Rossier, J. (1986) · Nature · doi:10.1038/321864a0 · Cited by 504 · see citing works

Neuronal Mechanisms of Habituation and Dishabituation of the Gill-Withdrawal Reflex in Aplysia

Castellucci, V. F., Pinsker, H. M., Kupfermann, I., & Kandel, E. R. (1970) · Science · doi:10.1126/science.167.3926.1745 · Cited by 501 · see citing works

Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors

Scanziani, M., Salin, P. A., Vogt, K. E., Malenka, R. C., & Nicoll, R. A. (1997) · Nature · doi:10.1038/385630a0 · Cited by 456 · see citing works

Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning

Cui, Y., Costa, R. M., Murphy, G. G., Elgersma, Y., Zhu, Y., Gutmann, D. H., Parada, L. F., Módy, I., & Silva, A. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.060 · Cited by 434 · see citing works

Initial phase 2 trial of a nicotinic agonist in schizophrenia

Freedman, R., Olincy, A., Buchanan, R. W., Harris, J. G., Gold, J. M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M. P., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071135 · Cited by 426 · see citing works

Role of serotonin in memory impairment.

Buhot, M.-C., Martin, S., & Segu, L. (2000) · Annals of Medicine · doi:10.3109/07853890008998828 · Cited by 419 · see citing works

Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia

Egan, M. F., Straub, R. E., Goldberg, T. E., Yakub, I., Callicott, J. H., Hariri, A. R., Mattay, V. S., Bertolino, A., Hyde, T. M., Weickert, C. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405077101 · Cited by 416 · see citing works

Muscarinic acetylcholine receptors as CNS drug targets

Langmead, C. J., Watson, J. M., & Reavill, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.009 · Cited by 413 · see citing works

α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity

Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., & Akaike, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008035200 · Cited by 412 · see citing works

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome

Berry-Kravis, E., Hessl, D., Coffey, S., Hervey, C., Schneider, A., Yuhas, J., Hutchison, J., Snape, M., Tranfaglia, M., Nguyen, D. V., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.063701 · Cited by 411 · see citing works

Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1

Hayashi-Takagi, A., Takaki, M., Graziane, N., Seshadri, S., Murdoch, H., Dunlop, A. J., Makino, Y., Seshadri, A. J., Ishizuka, K., Srivastava, D. P., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2487 · Cited by 399 · see citing works

Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor.

Bertrand, D., Galzi, J., Devillers‐Thiéry, A., Bertrand, S., & Changeux, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.6971 · Cited by 390 · see citing works

CREB: A mediator of long-term memory from mollusks to mammals

Frank, D. A., & Greenberg, M. E. (1994) · Cell · doi:10.1016/0092-8674(94)90394-8 · Cited by 369 · see citing works

GABAA receptor diversity and pharmacology

Möhler, H. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0284-3 · Cited by 359 · see citing works

Targeting the CREB pathway for memory enhancers

Tully, T., Bourtchouladze, R., Scott, R., & Tallman, J. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1061 · Cited by 355 · see citing works

Molecular Neuropharmacology: A Foundation for Clinical Neuroscience

Nestler, E. J., Hyman, S. E., Holtzman, D. M., & Malenka, R. C. (2001) · Cited by 345 · see citing works

Impairment of Hippocampal Mossy Fiber LTD in Mice Lacking mGluR2

Yokoi, M., Kobayashi, K., Manabe, T., Takahashi, T., Sakaguchi, I., Katsuura, G., Shigemoto, R., Ohishi, H., Nomura, S., Nakamura, K. D., et al. (1996) · Science · doi:10.1126/science.273.5275.645 · Cited by 340 · see citing works

The Physiological Role of 5-HT_2AReceptors in Working Memory

Williams, G. V., Rao, S. G., & Goldman-Rakic, P. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02843.2002 · Cited by 311 · see citing works

A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory

King, M. V., Marsden, C. A., & Fone, K. C. F. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.001 · Cited by 305 · see citing works

The histamine H3receptor: an attractive target for the treatment of cognitive disorders

Esbenshade, T. A., Browman, K. E., Bitner, R. S., Strakhova, M. I., Cowart, M. D., & Brioni, J. D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.147 · Cited by 302 · see citing works

Localization of the GLYT1 Glycine Transporter at Glutamatergic Synapses in the Rat Brain

Cubelos, B. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh147 · Cited by 291 · see citing works

Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders

Conn, P. J., Jones, C. K., & Lindsley, C. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.002 · Cited by 286 · see citing works

Subunit-Selective Modulation of GABA Type A Receptor Neurotransmission and Cognition in Schizophrenia

Lewis, D. A., Cho, R. Y., Carter, C. S., Eklund, K. E., Förster, S., Kelly, M. A., & Montrose, D. M. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030395 · Cited by 286 · see citing works

The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain

Burnet, P. W. J., Eastwood, S. L., Lacey, K., & Harrison, P. J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00104-x · Cited by 283 · see citing works

Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome

Dölen, G., & Bear, M. F. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.150722 · Cited by 278 · see citing works

alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability

Castro, N. G., & Albuquerque, E. X. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)80213-4 · Cited by 273 · see citing works

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

Krystal, J. H., Abi-Saab, W., Perry, E., D’Souza, D. C., Liu, N., Gueorguieva, R., McDougall, L., Hunsberger, T., Belger, A., Levine, L., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-004-1982-8 · Cited by 272 · see citing works

Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation.

Riedel, W. J., Klaassen, T., Deutz, N. E. P., van Someren, A., & van Praag, H. M. (1999) · Psychopharmacology · doi:10.1007/s002130050845 · Cited by 271 · see citing works

Sarcosine or D-Serine Add-on Treatment for Acute Exacerbation of Schizophrenia

Lane, H., Chang, Y., Liu, Y., Chiu, C., & Tsai, G. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1196 · Cited by 271 · see citing works

Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia

Grauer, S. M., Pulito, V. L., Navarra, R. L., Kelly, M. P., Kelley, C., Graf, R., Langen, B., Logue, S. F., Brennan, J. A., Jiang, L., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155994 · Cited by 270 · see citing works

Selective phosphodiesterase inhibitors: a promising target for cognition enhancement

Reneerkens, O. A. H., Rutten, K., Steinbusch, H. W. M., Blokland, A., & Prickaerts, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1273-x · Cited by 268 · see citing works

Therapeutic potential of histamine H3 receptor agonists and antagonists

Leurs, R., Blandina, P., Tedford, C. E., & Timmerman, H. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01201-2 · Cited by 265 · see citing works

GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon

Guidotti, A., Auta, J., Davis, J. M., Dong, E., Grayson, D. R., Veldic, M., Zhang, X., & Costa, E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2212-8 · Cited by 262 · see citing works

DOG BITES IN CHILDREN

Lillington, A. W., & Ross, M. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92316-3 · Cited by 261 · see citing works

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

Roth, B., Hanizavareh, S. M., & Blum, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1683-8 · Cited by 259 · see citing works

A Hippocampal NR2B Deficit Can Mimic Age-Related Changes in Long-Term Potentiation and Spatial Learning in the Fischer 344 Rat

Clayton, D. A., Mesches, M. H., Álvarez, E., Bickford, P. C., & Browning, M. D. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03628.2002 · Cited by 258 · see citing works

A review of the role of serotonin receptors in psychiatric disorders

Naughton, M., Mulrooney, J. B., & Leonard, B. E. (2000) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/1099-1077(200008)15:6 · Cited by 258 · see citing works

5-HT6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease

Upton, N., Chuang, T. T., Hunter, A. J., & Virley, D. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.008 · Cited by 257 · see citing works

Differential localization of phosphoinositide-linked metabotropic glutamate receptor (mGluR1) and the inositol 1,4,5-trisphosphate receptor in rat brain

Fotuhi, M., Sharp, A., Glatt, C., Hwang, P. M., von Krosigk, M., Snyder, S. H., & Dawson, T. M. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-05-02001.1993 · Cited by 247 · see citing works

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

GOFF, D. C., Tsai, G. E., Manoach, D. S., & Coyle, J. T. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1213 · Cited by 243 · see citing works

GABA and Schizophrenia: A Review of Basic Science and Clinical Studies

Wassef, A. A., Baker, J. D., & Kochan, L. D. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095349.32154.a5 · Cited by 243 · see citing works

An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

Dawson, G. R., Maubach, K. A., Collinson, N., Cobain, M., Everitt, B. J., MacLeod, A. M., Choudhury, H. I., McDonald, L. M., Pillai, G., Rycroft, W., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092320 · Cited by 241 · see citing works

Safety, Pharmacokinetics, and Effects on Cognitive Function of Multiple Doses of GTS-21 in Healthy, Male Volunteers

KITAGAWA, H., TAKENOUCHI, T., Azuma, R., Wesnes, K. A., Kramer, W. G., Clody, D. E., & Burnett, A. L. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300028 · Cited by 238 · see citing works

AMPA Receptor Potentiators for the Treatment of CNS Disorders

O’Neill, M. J., Bleakman, D., Zimmerman, D. M., & Nisenbaum, E. S. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043337508 · Cited by 223 · see citing works

Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task

Aultman, J. M., & Moghaddam, B. (2000) · Psychopharmacology · doi:10.1007/s002130000590 · Cited by 217 · see citing works

Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex

Ohishi, H., Ogawa-Meguro, R., Shigemoto, R., Kaneko, T., Nakanishi, S., & Mizuno, N. (1994) · Neuron · doi:10.1016/0896-6273(94)90459-6 · Cited by 213 · see citing works

5‐Hydroxytryptamine (5‐HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases

Reynolds, G. P., Mason, S., Meldrum, A., Keczer, S. D., Parties, H., Eglen, R. M., & Wong, E. H. F. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13303.x · Cited by 208 · see citing works

mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning

Ayala, J. E., Chen, Y., Banko, J. L., Sheffler, D. J., Williams, R. D., Telk, A. N., Watson, N. L., Xiang, Z., Zhang, Y., Jones, P. J., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.30 · Cited by 206 · see citing works

The β2 but not α7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice

Walters, C. L., Brown, S., Changeux, J.-P., Martin, B., & Damaj, M. I. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0295-x · Cited by 206 · see citing works

Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology.

Thomsen, M. S., Hansen, H. H., Timmerman, D. B., & Mikkelsen, J. (2010) · Current pharmaceutical design · doi:10.2174/138161210790170094 · Cited by 204 · see citing works

CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects

Barco, Á., Pittenger, C., & Kandel, E. R. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.1.101 · Cited by 201 · see citing works

PDE10A inhibition reverses subchronic PCP‐induced deficits in attentional set‐shifting in rats

Rodefer, J. S., Murphy, E. R., & Baxter, M. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03937.x · Cited by 199 · see citing works

Molecular Neuropharmacology: A Foundation for Clinical Neuroscience

Janicak, P. G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251 · Cited by 196 · see citing works

Association of DISC1 with autism and Asperger syndrome

Kilpinen, H., Ylisaukko‐oja, T., Hennah, W., Palo, O. M., Varilo, T., Vanhala, R., Wendt, T. N., von Wendt, L., Paunio, T., & Peltonen, L. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002031 · Cited by 193 · see citing works

Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus

Uslaner, J. M., Parmentier‐Batteur, S., Flick, R. B., Surles, N. O., Lam, J. S. H., McNaughton, C. H., Jacobson, M. A., & Hutson, P. H. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.022 · Cited by 193 · see citing works

Lurasidone in the Treatment of Acute Schizophrenia

Nakamura, M., Ogasa, M., Guarino, J. J., Phillips, D., Severs, J. M., Cucchiaro, J. B., & Loebel, A. D. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04905 · Cited by 191 · see citing works

Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia

Umbricht, D., Vollenweider, F. X., Schmid, L., Grübel, C., Skrabo, A., Huber, T., & Koller, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300005 · Cited by 187 · see citing works

ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities

Liu, F., Grauer, S. M., Kelley, C., Navarra, R. L., Graf, R., Zhang, G., Atkinson, P. J., Popiolek, M., Wantuch, C., Khawaja, X. Z., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136580 · Cited by 183 · see citing works

A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia

GOFF, D. C., Lamberti, J. S., Leon, A. C., Green, M. F., Miller, A. L., Patel, J. K., Manschreck, T. C., Freudenreich, O., & Johnson, S. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301444 · Cited by 181 · see citing works

The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents

van der Staay, F. J., Rutten, K., Bärfacker, L., DeVry, J., Erb, C., Heckroth, H., Karthaus, D., Tersteegen, A., van Kampen, M., Blokland, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.005 · Cited by 180 · see citing works

Glycine Transporter I Inhibitor, N-methylglycine (Sarcosine), Added to Clozapine for the Treatment of Schizophrenia

Lane, H., Huang, C.-L., Wu, P.-L., Liu, Y., Chang, Y., Lin, P., Chen, P., & Tsai, G. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.005 · Cited by 179 · see citing works

A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia

Lane, H., Lin, C., Huang, Y.-J., Liao, C.-H., Chang, Y.-C., & Tsai, G. E. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990939 · Cited by 179 · see citing works

Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders

Spooren, W. P. J. M., Ballard, T. M., Gasparini, F., Amalric, M., Mutel, V., & Schreiber, R. (2003) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000081783.35927.8f · Cited by 177 · see citing works

Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data

Black, M. D. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2065-6 · Cited by 176 · see citing works

L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors

Atack, J. R., Bayley, P. J., Seabrook, G. R., Wafford, K. A., McKernan, R. M., & Dawson, G. R. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.018 · Cited by 175 · see citing works

Improving Memory: A Role for Phosphodiesterases

Blokland, A., Schreiber, R. D., & Prickaerts, J. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698855 · Cited by 174 · see citing works

Assessing cognitive function in clinical trials of schizophrenia

Barnett, J. H., Robbins, T. W., Leeson, V. C., Sahakian, B. J., Joyce, E. M., & Blackwell, A. D. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.012 · Cited by 173 · see citing works

d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats

Karasawa, J.-I., Hashimoto, K., & Chaki, S. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.033 · Cited by 172 · see citing works

A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia

Buchanan, R. W., Keefe, R. S. E., Lieberman, J. A., Barch, D. M., Csernansky, J. G., Goff, D. C., Gold, J. M., Green, M. F., Jarskog, L. F., Javitt, D. C., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.052 · Cited by 172 · see citing works

Maintenance of superior learning and memory function in NR2B transgenic mice during ageing

Cao, X., Cui, Z., Feng, R., Tang, Y., Qin, Z., Mei, B., & Tsien, J. Z. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05431.x · Cited by 171 · see citing works

Identification of a genetic cluster influencing memory performance and hippocampal activity in humans

de Quervain, D. J. ‐., & Papassotiropoulos, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510212103 · Cited by 167 · see citing works

A Revised Excitotoxic Hypothesis of Schizophrenia: Therapeutic Implications

Deutsch, S. I., Rosse, R. B., Schwartz, B. L., & Mastropaolo, J. P. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200101000-00008 · Cited by 167 · see citing works

Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine‐induced seizure activity

Bymaster, F. P., Carter, P. A., Yamada, M., Gomeza, J., Wess, J., Hamilton, S. E., Nathanson, N. M., McKinzie, D. L., & Felder, C. C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02588.x · Cited by 167 · see citing works

Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia

Harrison, P. J., Lyon, L., Sartorius, L. J., Burnet, P., & Lane, T. A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089818 · Cited by 166 · see citing works

Mood disorders: Regulation by metabotropic glutamate receptors

Pilc, A., Chaki, S., Nowak, G., & Witkin, J. M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.09.021 · Cited by 163 · see citing works

5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus.

Andrade, R., & Chaput, Y. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24797-8 · Cited by 163 · see citing works

Involvement of histamine in the control of the waking state

Monti, J. M. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90592-q · Cited by 162 · see citing works

Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent

Higgins, G. A., Ballard, T. M., Kew, J. N. C., Richards, J. G., Kemp, J. A., Adam, G., Woltering, T. J., Nakanishi, S., & Mutel, V. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.018 · Cited by 158 · see citing works

RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors

Ballard, T. M., Knoflach, F., Prinssen, E. P. M., Borroni, E., Vivian, J. A., Basile, J., Gasser, R., Moreau, J., Wettstein, J. G., Buettelmann, B., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1357-7 · Cited by 156 · see citing works

Effects of mood and severity on memory processes in depression and mania.

Johnson, M. H., & Magaro, P. A. (1987) · Psychological Bulletin · doi:10.1037/0033-2909.101.1.28 · Cited by 154 · see citing works

Enhancement of Attentional Performance by Selective Stimulation of α4β2* nAChRs: Underlying Cholinergic Mechanisms

Howe, W. M., Ji, J., Parikh, V., Williams, S., Mocaër, E., Trocmé-Thibierge, C., & Sarter, M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.9 · Cited by 150 · cited 1× · see citing works

Classification and nomenclature of 5-HT receptors: a comment on current issues

Hoyer, D., & Martin, G. R. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00109-x · Cited by 149 · see citing works

Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system

Witkin, J. M., & Nelson, D. L. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.05.001 · Cited by 148 · see citing works

Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study

GOFF, D., CATHER, C., GOTTLIEB, J., EVINS, A., WALSH, J., RAEKE, L., OTTO, M., SCHOENFELD, D., & GREEN, M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.012 · Cited by 144 · see citing works

Metabotropic Glutamate Receptors in the Control of Mood Disorders

Witkin, J. M., Marek, G. J., Johnson, B., & Schoepp, D. D. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363302 · Cited by 140 · see citing works

AMPA receptor modulators as cognitive enhancers

LYNCH, G. S. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.09.009 · Cited by 138 · see citing works

Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function

Levin, E. D., & Rezvani, A. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.019 · Cited by 129 · see citing works

RG3487, a Novel Nicotinic α7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents

Wallace, T., Callahan, P., Tehim, A., Bertrand, D., Tombaugh, G., Wang, S.-J., Xie, W., Rowe, W., Ong, V., Graham, E., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.171892 · Cited by 129 · see citing works

Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties

Schechter, L. E., Smith, D. L., Rosenzweig-Lipson, S. J., Rizzo, S. J. S., Dawson, L. A., Marquis, K. L., Jones, D. P., Piesla, M. J., Andree, T. H., Nawoschik, S. P., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086363 · Cited by 129 · see citing works

Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments

Palo, O. M., Antila, M., Silander, K., Hennah, W., Kilpinen, H., Soronen, P., Tuulio‐Henriksson, A., Kieseppä, T., Partonen, T., Lönnqvist, J. K., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm207 · Cited by 128 · see citing works

Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome

Rueda, N., Flórez, J., & Martínez‐Cué, C. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.039 · Cited by 127 · see citing works

GABAA receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders

Charych, E. I., Liu, F., Moss, S. J., & Brandon, N. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.027 · Cited by 127 · see citing works

Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression

Feyissa, A. M., Woolverton, W. L., Miguel-Hidalgo, J. J., Wang, Z., Kyle, P. B., Hasler, G., Stockmeier, C. A., Iyo, A. H., & Karolewicz, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.018 · Cited by 126 · see citing works

Genetic Enhancement of Memory and Long-Term Potentiation but Not CA1 Long-Term Depression in NR2B Transgenic Rats

Wang, D., Cui, Z., Zeng, Q., Kuang, H., Wang, L. P., Tsien, J. Z., & Cao, X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007486 · Cited by 123 · see citing works

Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials

Schultheiss, D., Müller, S., Nager, W., Stief, C. G., Schlote, N., Udo Jonas, A., Asvestis, C., Johannes, S., & Münte, T. (2001) · World Journal of Urology · doi:10.1007/pl00007092 · Cited by 119 · see citing works

Enhanced long‐term potentiation and impaired learning in phosphodiesterase 4D‐knockout (PDE4D−/−) mice

Rutten, K., Misner, D., Works, M. G., Blokland, A., Novak, T. J., Santarelli, L., & Wallace, T. L. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06349.x · Cited by 119 · see citing works

Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

Rollema, H., Hajós, M., Seymour, P. A., Kozak, R., Majchrzak, M. J., Guanowsky, V., Horner, W. E., Chapin, D. S., Hoffmann, W. E., Johnson, D. E., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.033 · Cited by 117 · see citing works

Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimers Disease

Maher‐Edwards, G., Zvartau-Hind, M. E., Hunter, A. J., Gold, M., Hopton, G., Jacobs, G., Davy, M., & Williams, P. M. (2010) · Current Alzheimer Research · doi:10.2174/156720510791383831 · Cited by 117 · see citing works

Evaluation of Dimebon in cellular model of Huntington's disease

Wu, J., Li, Q., & Борисович, Б. И. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-15 · Cited by 117 · see citing works

Preclinical and clinical pharmacology of the GABAA receptor α5 subtype-selective inverse agonist α5IA

Atack, J. R. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.09.001 · Cited by 116 · see citing works

Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice

Meguro, K. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00248-u · Cited by 113 · see citing works

Blockade of alcohol's amnestic activity in humans by an α5 subtype benzodiazepine receptor inverse agonist

Nutt, D., Besson, M. J., Wilson, S. J., Dawson, G. R., & Lingford-Hughes, A. R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.008 · Cited by 109 · see citing works

Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders

Roncarati, R., Scali, C., Comery, T., Grauer, S. M., Aschmi, S., Bothmann, H., Jow, B., Kowal, D., Gianfriddo, M., Kelley, C., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.150094 · Cited by 109 · see citing works

Transient and long‐lasting actions of 5‐HT on rat dentate gyrus neurones in vitro.

Piguet, P., & Galvan, M. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020469 · Cited by 108 · see citing works

Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist

Langmead, C. J., Fry, V. A. H., Forbes, I. T., Branch, C. L., Christopoulos, A., Wood, M. D., & Herdon, H. J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017814 · Cited by 108 · see citing works

Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition

Higgins, G. A., Ballard, T. M., Huwyler, J., Kemp, J. A., & Gill, R. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00402-1 · Cited by 106 · see citing works

Bidirectional effects of β-carbolines and benzodiazepines on cognitive processes

Jensen, L. H., Stephens, D. N., Sarter, M. F., & Petersen, E. N. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90104-3 · Cited by 104 · see citing works

Identification of the primary muscarinic autoreceptor subtype in rat striatum as m2 through a correlation of in vivo microdialysis and in vitro receptor binding data.

Billard, W., Binch, H., Crosby, G., & McQuade, R. D. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09528-x · Cited by 103 · see citing works

Positive Allosteric Modulation of Metabotropic Glutamate 5 (mGlu5) Receptors Reverses N-Methyl-D-Aspartate Antagonist-Induced Alteration of Neuronal Firing in Prefrontal Cortex

Lecourtier, L., Homayoun, H., Tamagnan, G. D., & Moghaddam, B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.003 · Cited by 101 · see citing works

Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade

Stefani, M. R., & Moghaddam, B. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.01.028 · Cited by 100 · see citing works

Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment

Harich, S., Groß, G., & Bespalov, A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0742-y · Cited by 100 · see citing works

Histamine H3receptor ligands break ground in a remarkable plethora of therapeutic areas

Wijtmans, M., Leurs, R., & de Esch, I. J. P. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.967 · Cited by 100 · see citing works

Deficits in the expression of the NR2B subunit in the hippocampus of aged Fisher 344 rats

Clayton, D. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00196-2 · Cited by 99 · see citing works

Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine

Curran, H. V., Pooviboonsuk, P., Dalton, J. A., & Lader, M. H. (1998) · Psychopharmacology · doi:10.1007/s002130050482 · Cited by 98 · see citing works

Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats.

Rezvani, A., Kholdebarin, E., Brucato, F., Callahan, P., Lowe, D., & Levin, E. (2009) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.018 · Cited by 97 · see citing works

Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone

Harvey, P. D., Ogasa, M., Cucchiaro, J. B., Loebel, A. D., & Keefe, R. S. E. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.01.004 · Cited by 96 · see citing works

An inverse agonist selective for α5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze

Collinson, N., Atack, J. R., Laughton, P., Dawson, G. R., & Stephens, D. N. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0361-z · Cited by 96 · see citing works

Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification.

Javitt, D. C. (2009) · PubMed · Cited by 94 · see citing works

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia

Shiina, A., Shirayama, Y., Niitsu, T., Hashimoto, T., Yoshida, T., Hasegawa, T., Haraguchi, T., Kanahara, N., Shiraishi, T., Fujisaki, M., et al. (2010) · Annals of General Psychiatry · doi:10.1186/1744-859x-9-27 · Cited by 94 · see citing works

In Vitro Binding Characteristics of a New Selective Group II Metabotropic Glutamate Receptor Radioligand, [3H]LY354740, in Rat Brain

Schaffhauser, H., Richards, J. G., Cartmell, J., Chaboz, S., Kemp, J. A., Klingelschmidt, A., Messer, J., Stadler, H., Woltering, T. J., & Mutel, V. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.2.228 · Cited by 93 · see citing works

AMPA potentiator treatment of cognitive deficits in Alzheimer disease

Chappell, A. S., Gonzales, C., Williams, J., Witte, M. M., Mohs, R. C., & Sperling, R. (2007) · Neurology · doi:10.1212/01.wnl.0000260240.46070.7c · Cited by 89 · cited 2× · see citing works

Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition

Devan, B. D., Bowker, J. L., Duffy, K. B., Bharati, I. S., Jimenez, M. A., Sierra‐Mercado, D., Nelson, C. M., Spangler, E. L., & Ingram, D. K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0232-z · Cited by 89 · see citing works

Serotonergic targets in depression.

Middlemiss, D. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00116-3 · Cited by 88 · see citing works

Measuring the neuromodulatory effects of drugs in man with positron emission tomography

Friston, K. J., Grasby, P. M., Bench, C. J., Frith, C., Cowen, P. J., Liddle, P. F., Frackowiak, R. S. J., & Dolan, R. J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90345-8 · Cited by 87 · see citing works

Association Between Genes of Disrupted in Schizophrenia 1 (DISC1) Interactors and Schizophrenia Supports the Role of the DISC1 Pathway in the Etiology of Major Mental Illnesses

Tomppo, L., Hennah, W., Lahermo, P., Loukola, A., Tuulio‐Henriksson, A., Suvisaari, J., Partonen, T., Ekelund, J., Lönnqvist, J. K., & Peltonen, L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.014 · Cited by 84 · see citing works

5-Hydroxytryptamine7 Receptor Activation Decreases Slow Afterhyperpolarization Amplitude in CA3 Hippocampal Pyramidal Cells

Bacon, W. L., & Beck, S. G. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39121-9 · Cited by 83 · see citing works

d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats

Shimazaki, T., Kaku, A., & Chaki, S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1794-y · Cited by 81 · see citing works

5-Hydroxytryptamine4 receptors reduce afterhyperpolarization in hippocampus by inhibiting calcium-induced calcium release.

Torres, G. E., Arfken, C. L., & Andrade, R. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09560-4 · Cited by 81 · see citing works

Presynaptic group II metabotropic glutamate receptors reduce stimulated and spontaneous transmitter release in human dentate gyrus

Dietrich, D., Kral, T., Clusmann, H., Friedl, M., & Schramm, J. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00193-9 · Cited by 79 · see citing works

S33138 (N-[4-[2-[(3 aS,9 bR)-8-cyano-1,3 a,4,9 b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3 H)-yl)-ethyl]phenyl-acetamide), a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent: III. Actions in Models of Therapeutic Activity and Induction of Side Effects

Millan, M. J., Loiseau, F., Dekeyne, A., Gobert, A., Flik, G., Cremers, T. I. F. H., Rivet, J., Sicard, D., Billiras, R., & Brocco, M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134536 · Cited by 79 · see citing works

Dissociable Hormonal, Cognitive and Mood Responses to Neuroendocrine Challenge Evidence for Receptor-Specific Serotonergic Dysregulation in Depressed Mood

Riedel, W. J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00361-x · Cited by 78 · see citing works

The role of histamine on cognition

Alvarez, E. O. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.010 · Cited by 77 · see citing works

Memories are Made of This (Perhaps): A Review of Serotonin 5-HT6 Receptor Ligands and Their Biological Functions

Russell, M. G. N., & Dias, R. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026023393877 · Cited by 76 · see citing works

A placebo-controlled study of sildenafil effects on cognition in schizophrenia

GOFF, D. C., Cather, C., Freudenreich, O., Henderson, D. C., Evins, A. E., Maravić, M. C., & Walsh, J. P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1278-5 · Cited by 76 · see citing works

Nicotinic Agonists and Psychosis

Simosky, J. K., Stevens, K. E., & Freedman, R. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007024606168 · Cited by 75 · see citing works

In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA Receptor α5 Subtype-Selective Inverse Agonist

Atack, J. R., Maubach, K. A., Wafford, K. A., O'Connor, D. V., Rodrigues, A. D., Evans, D. C., Tattersall, F. D., Chambers, M. S., MacLeod, A. M., Eng, W., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157636 · Cited by 72 · see citing works

Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1

Kew, J. N. C., Ducarre, J.-M., Pflimlin, M., Mutel, V., & Kemp, J. A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00118-0 · Cited by 72 · see citing works

Challenges for and current status of research into positive modulators of AMPA receptors

Ward, S. E., Bax, B. D., & Harries, M. H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00726.x · Cited by 72 · see citing works

erratum: Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes

Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J., Martin, J. R., Bluethmann, H., & Möhler, H. (2000) · Nature · doi:10.1038/35007116 · Cited by 71 · see citing works

A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell

Karasawa, J.-I., Yoshimizu, T., & Chaki, S. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.058 · Cited by 70 · see citing works

Structural Determinants of Allosteric Agonism and Modulation at the M4 Muscarinic Acetylcholine Receptor

Nawaratne, V., Leach, K., Felder, C. C., Sexton, P. M., & Christopoulos, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125096 · Cited by 70 · see citing works

Effects of histamine H3 receptor antagonists in two models of spatial learning

Komater, V. A., Buckley, M. J., Browman, K. E., Pan, J. B., Hancock, A. A., Decker, M. W., & Fox, G. B. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.11.008 · Cited by 70 · see citing works

Brief-lifetime, fast-inactivating ion channels account for the α-bungarotoxin-sensitive nicotinic response in hippocampal neurons

Castro, N. G., & Albuquerque, E. X. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90876-m · Cited by 70 · see citing works

Blockade of dopamine D3 receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D1 receptor agonists, but not of D2 antagonists

Loiseau, F., & Millan, M. J. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.07.012 · Cited by 69 · see citing works

Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan

Browman, K. E., Komater, V. A., Curzon, P., Rueter, L. E., Hancock, A. A., Decker, M. W., & Fox, G. B. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.11.001 · Cited by 68 · see citing works

Effects of 5-HT on memory and the hippocampus: model and data.

Meeter, M., Talamini, L., Schmitt, J. A. J., & Riedel, W. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300869 · Cited by 68 · see citing works

Density and pharmacology of α5 subunit-containing GABAA receptors are preserved in hippocampus of Alzheimer’s disease patients

Howell, O. W., Atack, J. R., Dewar, D., McKernan, R. M., & Sur, C. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00163-9 · Cited by 67 · see citing works

Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat

Higgins, G. A., Ballard, T. M., Enderlin, M., Haman, M., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2203-9 · Cited by 67 · see citing works

Metabotropic glutamate receptor subtype 5 antagonism in learning and memory

Simonyi, Á., Schachtman, T. R., & Christoffersen, G. R. J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.039 · Cited by 66 · see citing works

Negative regulation of neurogenesis and spatial memory by NR2B‐containing NMDA receptors

Hu, M. Y., Sun, Y., Zhou, Q., Chen, L., Hu, Y. F., Luo, C., Wu, J., Xu, J., Li, L., & Zhu, D. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05554.x · Cited by 64 · see citing works

Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats

Medhurst, A. D., Briggs, M. A., Bruton, G., Calver, A. R., Chessell, I. P., Crook, B., Davis, J. B., Davis, R. P., Foley, A., Heslop, T., et al. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.007 · Cited by 64 · see citing works

Phosphodiesterase Inhibitors as Potential Cognition Enhancing Agents

Schmidt, C. J. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790411009 · Cited by 64 · see citing works

Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator

Rosenbrock, H., Kramer, G., Hobson, S., Koroś, E., Grundl, M. A., Grauert, M., Reymann, K. G., & Schröder, U. H. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.057 · Cited by 62 · see citing works

Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion

van Donkelaar, E. L., Rutten, K., Blokland, A., Akkerman, S., Steinbusch, H. W. M., & Prickaerts, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.027 · Cited by 62 · see citing works

Metabotropic glutamate mGlu1 receptor stimulation and blockade: Therapeutic opportunities in psychiatric illness

Lesage, A., & Steckler, T. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.12.043 · Cited by 62 · see citing works

Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects

Hart, R. P., Colenda, C. C., & Hamer, R. M. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.1.73 · Cited by 58 · see citing works

Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with Auditory Event-Related Potentials and Prepulse Inhibition of Startle

Halene, T. B., & Siegel, S. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138586 · Cited by 58 · see citing works

Chapter III Metabotropic glutamate receptors — immunocytochemical and in situ hybridization analyses

Shigemoto, R., & Mizuno, N. (2000) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(00)80044-5 · Cited by 57 · see citing works

Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys

Spinelli, S., Ballard, T. M., Gatti‐McArthur, S., Richards, G. J., Kapps, M., Woltering, T. J., Wichmann, J., Stadler, H., Feldon, J., & Pryce, C. R. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2126-x · Cited by 57 · see citing works

Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population

Numata, S., Ueno, S., Iga, J., Song, H., Nakataki, M., Tayoshi, S., Sumitani, S., Tomotake, M., Itakura, M., Sano, A., et al. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.01.013 · Cited by 57 · see citing works

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292 · see citing works

Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline

Ballinger, E. C., Ananth, M. R., Talmage, D. A., & Role, L. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.006 · Cited by 735 · see citing works

Working memory improvement with non-invasive brain stimulation of the dorsolateral prefrontal cortex: A systematic review and meta-analysis

Brunoni, A. R., & Vanderhasselt, M.-A. (2014) · Brain and Cognition · doi:10.1016/j.bandc.2014.01.008 · Cited by 669 · see citing works

Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis

Begemann, M. J., Brand, B. A., Ćurčić-Blake, B., Aleman, A., & Sommer, I. E. (2020) · Psychological Medicine · doi:10.1017/s0033291720003670 · Cited by 368 · see citing works

Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats

Mørk, A., Montezinho, L. P., Miller, S., Trippodi-Murphy, C., Plath, N., Li, Y., Gulinello, M. E., & Sánchez, C. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.019 · Cited by 298 · see citing works

Inflammation and the two-hit hypothesis of schizophrenia

Feigenson, K. A., Kusnecov, A., & Silverstein, S. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.006 · Cited by 280 · see citing works

The vagal innervation of the gut and immune homeostasis

Matteoli, G., & Boeckxstaens, G. E. (2013) · Gut · doi:10.1136/gutjnl-2012-302550 · Cited by 276 · see citing works

Neurological phenotypes for Down syndrome across the life span

Lott, I. T. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-54299-1.00006-6 · Cited by 225 · see citing works

Merging old and new perspectives on nicotinic acetylcholine receptors

Papke, R. L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.029 · Cited by 183 · see citing works

Aerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health Treatment

Kandola, A., Hendrikse, J., Lucassen, P. J., & Yücel, M. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00373 · Cited by 155 · see citing works

Memory enhancement: consolidation, reconsolidation and insulin-like growth factor 2

Alberini, C. M., & Chen, D. Y. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.12.007 · Cited by 127 · see citing works

Nicotinic Activity of Arecoline, the Psychoactive Element of "Betel Nuts", Suggests a Basis for Habitual Use and Anti-Inflammatory Activity

Papke, R. L., Horenstein, N. A., & Stokes, C. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140907 · Cited by 127 · see citing works

Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how

Hornberg, J. J., Laursen, M., Brenden, N., Persson, M., Thougaard, A., Toft, D. B., & Mow, T. J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.008 · Cited by 115 · see citing works

Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders

Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2016) · Journal of Dual Diagnosis · doi:10.1080/15504263.2016.1146383 · Cited by 101 · see citing works

Evidence for Broad Versus Segregated Projections from Cholinergic and Noradrenergic Nuclei to Functionally and Anatomically Discrete Subregions of Prefrontal Cortex

Chandler, D. J., & Waterhouse, B. D. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00020 · Cited by 99 · see citing works

The Phosphodiesterase 10 Positron Emission Tomography Tracer, [18F]MNI-659, as a Novel Biomarker for Early Huntington Disease

Russell, D., Barret, O., Jennings, D. L., Friedman, J. H., Tamagnan, G. D., Thomae, D., Alagille, D., Morley, T. J., Papin, C., Papapetropoulos, S., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1954 · Cited by 96 · see citing works

Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors

Froestl, W., Muhs, A., & Pfeifer, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121186 · Cited by 91 · see citing works

Circadian dynamics in measures of cortical excitation and inhibition balance

Chellappa, S. L., Gaggioni, G., Ly, J. Q. M., Papachilleos, S., Borsu, C., Brzozowski, A., Rosanova, M., Sarasso, S., Luxen, A., Middleton, B., et al. (2016) · Scientific Reports · doi:10.1038/srep33661 · Cited by 84 · see citing works

5-HT systems: emergent targets for memory formation and memory alterations

Meneses, A. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0026 · Cited by 79 · see citing works

Inhibition of α5 γ-Aminobutyric Acid Type A Receptors Restores Recognition Memory After General Anesthesia

Zurek, A. A., Bridgwater, E. M., & Orser, B. A. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31824720da · Cited by 79 · see citing works

The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders

Peyrovian, B., Rosenblat, J. D., Pan, Z., Iacobucci, M., Brietzke, E. M., & McIntyre, R. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.001 · Cited by 70 · see citing works

Dual inhibitor of PDE7 and GSK-3 – VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice

Lipina, T. V., Palomo, V., Gil, C., Martı́nez, A., & Roder, J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.032 · Cited by 58 · see citing works

An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients

Gilleen, J., Yakub, F., Davison, C., Kerins, S., Valdearenas, L., Uz, T., Lahu, G., Tsai, M. C., Ogrinc, F., Reichenberg, A., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5134-y · Cited by 53 · see citing works

Prenatal maternal factors in the development of cognitive impairments in the offspring

Richetto, J., & Riva, M. A. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2014.03.005 · Cited by 51 · see citing works

Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats

Shi, J., Xue, W., Zhao, W., & Li, K.-X. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.147 · Cited by 50 · see citing works

Cognitive dysfunction in individuals with cocaine use disorder: Potential moderating factors and pharmacological treatments.

Mahoney, J. J. (2018) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000245 · Cited by 44 · see citing works

PWZ-029, an inverse agonist selective for α5 GABAA receptors, improves object recognition, but not water-maze memory in normal and scopolamine-treated rats

Milić, M., Stamenić, T. T., Joksimovic, S. M., Biawat, P., Rallapalli, S., Divljaković, J., Radulović, T., Cook, J. M., & Savić, M. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.016 · Cited by 43 · see citing works

Cerebrospinal fluid norepinephrine and cognition in subjects across the adult age span

Wang, L. Y., Murphy, R. R., Hanscom, B. S., Li, G., Millard, S. P., Petrie, E. C., Galasko, D. R., Sikkema, C. L., Raskind, M. A., Wilkinson, C. W., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.007 · Cited by 35 · see citing works

Reducing Gabaergic Inhibition Restores Cognitive Functions in a Mouse Model of Down Syndrome

Potier, M.-C., Braudeau, J., Dauphinot, L., & Delatour, B. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660185 · Cited by 34 · see citing works

The clinical importance of the anti-inflammatory vagovagal reflex.

Boeckxstaens, G. (2013) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53491-0.00011-0 · Cited by 29 · see citing works

Nicotinic α7 and α4β2 agonists enhance the formation and retrieval of recognition memory: Potential mechanisms for cognitive performance enhancement in neurological and psychiatric disorders

McLean, S. L., Grayson, B., Marsh, S., Zarroug, S. H. O., Harte, M., & Neill, J. C. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.08.037 · Cited by 33 · see citing works

Towards a Smart Population: A Public Health Framework for Cognitive Enhancement

Lucke, J. C., & Partridge, B. (2012) · Neuroethics · doi:10.1007/s12152-012-9167-3 · Cited by 33 · see citing works

Phosphodiesterase: An Interface Connecting Cognitive Deficits to Neuropsychiatric and Neurodegenerative Diseases

Wang, Z., Zhang, Y., Zhang, H., & Li, Y. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140826115559 · Cited by 33 · see citing works

Nicotinic Receptors and Attention

Hahn, B. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_5 · Cited by 32 · see citing works

Variable maternal stress in rats alters locomotor activity, social behavior, and recognition memory in the adult offspring

Wilson, C., & Terry, A. V. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.015 · Cited by 32 · see citing works

Histamine: an undercover agent in multiple rare diseases?

Pino‐Ángeles, A., Reyes‐Palomares, A., Melgarejo, E., & Sánchez‐Jiménez, F. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01566.x · Cited by 31 · see citing works

Relationship Between Glycine Transporter 1 Inhibition as Measured with Positron Emission Tomography and Changes in Cognitive Performances in Nonhuman Primates

Castner, S. A., Murthy, N. V., Ridler, K., Herdon, H. J., Roberts, B. M., Weinzimmer, D. P., Huang, Y. H., Zheng, M.-Q., Rabiner, E. A., Gunn, R. N., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.4 · Cited by 30 · see citing works

Silent agonists for α7 nicotinic acetylcholine receptors

Papke, R. L., Quadri, M., & Gulsevin, A. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106736 · Cited by 28 · see citing works

Ligand selectivity hotspots in serotonin GPCRs

Simon, Í. A., Bjørn-Yoshimoto, W. E., Harpsøe, K., Iliadis, S., Svensson, B. R., Jensen, A. A., & Gloriam, D. E. I. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.09.012 · Cited by 26 · see citing works

Ciproxifan improves working memory through increased prefrontal cortex neural activity in sleep-restricted mice

Chauveau, F., Laudereau, K., Libourel, P., Gervasoni, D., Thomasson, J., Poly‐Thomasson, B., Piérard, C., & Béracochéa, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.04.017 · Cited by 27 · see citing works

Synthesis of novel cognition enhancers with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at γ-aminobutyric acid type A (GABAA) receptor

Guerrini, G., Ciciani, G., Costanzo, A., Daniele, S., Martini, C., Ghelardini, C., Mannelli, L. D. C., & Ciattini, S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.02.027 · Cited by 26 · see citing works

Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update

Khan, S. S., Khatik, G. L., & Datusalia, A. K. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411083922 · Cited by 25 · see citing works

Translating Discoveries into Medicine: Psychiatric Drug Development in 2011

Brady, L. S., & Insel, T. R. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.106 · Cited by 25 · see citing works

Inhibiting glycine transporter-1 facilitates cocaine–cue extinction and attenuates reacquisition of cocaine-seeking behavior

Dhonnchadha, B. Á. N., Pinard, E., Alberati, D., Wettstein, J. G., Spealman, R. D., & Kantak, K. M. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.09.017 · Cited by 25 · see citing works

Alternative pharmacologic targets for the treatment of schizophrenia

Miyamoto, S., Jarskog, L. F., & Fleischhacker, W. W. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835d8296 · Cited by 23 · see citing works

Impact of 2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-D-glucoside on cognitive deficits in animal models of Alzheimer’s disease: a systematic review

Sheng, C., Peng, W., Chen, Z., Cao, Y., Gong, W., Xia, Z.-A., Wang, Y., Su, N.-X., & Wang, Z. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1313-8 · Cited by 24 · see citing works

Predicting targets of compounds against neurological diseases using cheminformatic methodology

Nikolic, K. M., Mavridis, L., Bautista‐Aguilera, Ó. M., Marco‐Contelles, J., Stark, H., Carreiras, M. C., Rossi, I., Massarelli, P., Agbaba, D. D., Ramsay, R. R., et al. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9816-1 · Cited by 22 · see citing works

Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects

Hahn, B., Shrieves, M. E., Olmstead, C. K., Yuille, M. B., Chiappelli, J., Pereira, E. F. R., Albuquerque, E. X., & Fawcett, W. P. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05363-4 · Cited by 22 · see citing works

Nicotine–morphine interactions at α4β2, α7 and α3⁎ nicotinic acetylcholine receptors

Talka, R., Salminen, O., Whiteaker, P., Lukas, R. J., & Tuominen, R. K. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.005 · Cited by 21 · see citing works

Dynamic Regulation of Synaptic Maturation State by Voltage-Gated A-Type K+Channels in CA1 Hippocampal Pyramidal Neurons

Kim, E., & Hoffman, D. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2373-12.2012 · Cited by 21 · see citing works

Glycine Transporter-1 Inhibition Preceding Extinction Training Inhibits Reacquisition of Cocaine Seeking

Achat‐Mendes, C., Dhonnchadha, B. Á. N., Platt, D. M., Kantak, K. M., & Spealman, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.155 · Cited by 21 · see citing works

Pairing Cholinergic Enhancement with Perceptual Training Promotes Recovery of Age-Related Changes in Rat Primary Auditory Cortex

Voss, P., Thomas, M. E., Chou, C. Y. C., Cisneros-Franco, J. M., Ouellet, L., & de Villers‐Sidani, E. (2015) · Neural Plasticity · doi:10.1155/2016/1801979 · Cited by 21 · see citing works

Cognitive Improvements in a Mouse Model with Substituted 1,2,3-Triazole Agonists for Nicotinic Acetylcholine Receptors

Arunrungvichian, K., Boonyarat, C., Fokin, V. V., Taylor, P., & Vajragupta, O. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00059 · Cited by 21 · see citing works

Dissociation of nicotinic α7 and α4/β2 sub-receptor agonists for enhancing learning and attentional filtering in nonhuman primates

Azimi, M., Oemisch, M., & Womelsdorf, T. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05430-w · Cited by 19 · see citing works

Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review

Mistarz, N. T., Andersen, K., Nielsen, A. S., Goudriaan, A. E., Michel, T. M., Skøt, L., Nielsen, D. G., & Mellentin, A. I. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.038 · Cited by 18 · see citing works

Membrane-mediated interaction of non-conventional snake three-finger toxins with nicotinic acetylcholine receptors

Shenkarev, Z. O., Chesnokov, Y. M., Zaigraev, M. M., Chugunov, A. O., Kulbatskii, D. S., Kocharovskaya, M. V., Paramonov, A. S., Bychkov, M. L., Shulepko, M. A., Nolde, D. E., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04308-6 · Cited by 18 · see citing works

The stereotypy‐inducing and OCD‐like effects of chronic ‘binge’ cocaine are modulated by distinct subtypes of nicotinic acetylcholine receptors

Metaxas, A., Keyworth, H., Yoo, J.-H., Chen, Y., Kitchen, I., & Bailey, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02023.x · Cited by 18 · see citing works

The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial

Reddy, S., Fayyad, R., Edgar, C. J., Guico-Pabia, C. J., & Wesnes, K. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116631649 · Cited by 17 · see citing works

Facilitation and inhibition of firing activity and N-methyl-D-aspartate-evoked responses of CA1 hippocampal pyramidal cells by alpha7 nicotinic acetylcholine receptor selective compounds in vivo

Bali, Z. K., Nagy, L. V., Budai, D., & Hernádi, I. (2019) · Scientific Reports · doi:10.1038/s41598-019-45796-7 · Cited by 16 · see citing works

Decreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats

Burke, D. A., Heshmati, P., Kholdebarin, E., & Levin, E. D. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.030 · Cited by 15 · see citing works

Synthesis, spectroscopic characterization, photochemical and photophysical properties and biological activities of ruthenium complexes with mono- and bi-dentate histamine ligand

Cardoso, C. R., de Aguiar, I., Camilo, M. R., Lima, M. V. S., Ito, A. S., Baptista, M. S., Pavani, C., Venâncio, T., & Carlos, R. M. (2012) · Dalton Transactions · doi:10.1039/c2dt12136k · Cited by 15 · see citing works

Increased gamma oscillations during voluntary selection processes in adult patients with attention deficit/hyperactivity disorder

Karch, S., Segmiller, F. M., Hantschk, I., Cerovecki, A., Opgen-Rhein, M., Hock, B., Dargel, S., Leicht, G., Hennig‐Fast, K., Riedel, M. J., et al. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.07.017 · Cited by 15 · see citing works

Temporal dynamics of cholinergic activity in the septo-hippocampal system

Kopsick, J. D., Hartzell, K., Lazaro, H., Nambiar, P., Hasselmo, M. E., & Dannenberg, H. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.957441 · Cited by 14 · see citing works

Screening and personalizing nootropic drugs and cognitive modulator regimens in silico

Jellen, L. C., Aliper, A. M., Buzdin, A. A., & Zhavoronkov, A. A. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00004 · Cited by 14 · see citing works

Allosterically Potentiated α7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium

Miller, D. R., Khoshbouei, H., Garai, S., Cantwell, L., Stokes, C. A., Thakur, G. A., & Papke, R. L. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000012 · Cited by 14 · see citing works

Sensitive and precise HPLC method with back‐extraction clean‐up step for the determination of sildenafil in rat plasma and its application to a pharmacokinetic study

Strach, B., Wyska, E., Pociecha, K., Krupa, A., & Jachowicz, R. (2015) · Biomedical Chromatography · doi:10.1002/bmc.3459 · Cited by 14 · see citing works

Role of the cholinesterase inhibitors in the treatment of schizophrenia

Pae, C. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.762355 · Cited by 14 · see citing works

Reduced cortical neurotransmitter receptor complex levels in fetal Down syndrome brain

Keihan Falsafi, S., Dierssen, M., Ghafari, M., Pollak, A., & Lubec, G. (2016) · Amino Acids · doi:10.1007/s00726-015-2062-6 · Cited by 13 · see citing works

Pleiotropic Locus for Emotion Recognition and Amygdala Volume Identified Using Univariate and Bivariate Linkage

Knowles, E. E. M., McKay, D., Kent, J. W., Sprooten, E., Carless, M. A., Curran, J. E., Almeida, M., Dyer, T. D., Göring, H. H. H., Olvera, R. L., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14030311 · Cited by 13 · see citing works

Effects of rivastigmine and memantine alone and in combination on learning and memory in rats with scopolamine-induced amnesia

Yanev, P. G., Dimitrova, D. S., & Getova, D. P. (2015) · Open Medicine · doi:10.1515/med-2015-0050 · Cited by 13 · see citing works

Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children

Tzang, R., Chang, Y., Tsai, G. E., & Lane, H. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116658986 · Cited by 13 · see citing works

Nicotinic modulation of intrinsic brain networks in schizophrenia

Smucny, J., & Tregellas, J. R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.011 · Cited by 12 · see citing works

Neurotransmitters and Memory

Meneses, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408139-0.00002-x · Cited by 12 · see citing works

Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from 18F-FDG PET brain persistent homology network

Hsu, T., Fuh, J., Wang, D., Chen, L., Chang, C.-J., Huang, W.-S., Wu, H., & Guo, W. (2021) · Scientific Reports · doi:10.1038/s41598-021-84722-8 · Cited by 11 · see citing works

IUPHAR review: Moving beyond dopamine-based therapeutic strategies for schizophrenia

Moran, P. M., & Granger, K. T. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107727 · Cited by 12 · see citing works

Human Nicotinic Acetylcholine Receptors: Part I—Structure, Function, and Role in Neuromuscular Transmission and CNS Functioning

Kulbatskii, D. S., Bychkov, M. L., & Lyukmanova, E. N. (2018) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162018060043 · Cited by 11 · see citing works

Nicotinic receptor pharmacology in silico: Insights and challenges

Gulsevin, A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108257 · Cited by 11 · see citing works

The monoaminergic stabilizer (−)-OSU6162 reverses delay-dependent natural forgetting and improves memory impairment induced by scopolamine in mice

Nilsson, M. K. L., & Carlsson, M. L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.017 · Cited by 11 · see citing works

Learning and memory in the forced swimming test: effects of antidepressants having varying degrees of anticholinergic activity

Enginar, N., Yamantürk-Çelik, P., Nurten, A., & Güney, D. B. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1236-4 · Cited by 11 · see citing works

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[indol-3-yl-Methylene]-1 H -pyrazol-5(4 H )-one derivatives

Jing, L., Wang, L., Zhao, Y., Tan, R., Xing, X., Liu, T., Huang, W., Luo, Y., & Li, Z. (2012) · Journal of Chemical Research · doi:10.3184/174751912x13501278349974 · Cited by 11 · see citing works

In Silico Modeling of the α7 Nicotinic Acetylcholine Receptor: New Pharmacological Challenges Associated with Multiple Modes of Signaling

Gulsevin, A., Papke, R. L., & Horenstein, N. A. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200130105256 · Cited by 11 · see citing works

N-(4-Hydroxyphenyl)-3,4,5-trimethoxybenzamide derivatives as potential memory enhancers: synthesis, biological evaluation and molecular simulation studies

Piplani, P., Sharma, M., Mehta, P., & Malik, R. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1336943 · Cited by 10 · see citing works

Comparison of the effects of Sertindole and Olanzapine on Cognition (SEROLA): a double-blind randomized 12-week study of patients diagnosed with schizophrenia

Nielsen, R. E., Odur, F., Østergaard, T., Munk‐Jørgensen, P., & Nielsen, J. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125313499065 · Cited by 9 · see citing works

Treatments and compositions for attention deficit hyperactivity disorder: a patent review

Molina‐Carballo, A., Checa-Ros, A., & Muñoz‐Hoyos, A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1182989 · Cited by 9 · see citing works

Uncoupling DISC1 × D2R Protein-Protein Interactions Facilitates Latent Inhibition in Disc1-L100P Animal Model of Schizophrenia and Enhances Synaptic Plasticity via D2 Receptors

Lipina, T. V., Beregovoy, N. A., Tkachenko, A. A., Петрова, Е. С., Starostina, M. V., Zhou, Q., & Li, S. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00031 · Cited by 8 · see citing works

The Allosteric Activation of α7 nAChR by α-Conotoxin MrIC Is Modified by Mutations at the Vestibular Site

Gulsevin, A., Papke, R. L., Stokes, C. A., Tran, H. N. T., Jin, A., Vetter, I., & Meiler, J. (2021) · Toxins · doi:10.3390/toxins13080555 · Cited by 8 · see citing works

Chronic treatment with the serotonin 2A/2C receptor antagonist SR 46349B enhances the retention and efficiency of rule-guided behavior in mice

Dougherty, J. P., & Oristaglio, J. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.04.002 · Cited by 8 · see citing works

Stable desensitization of α7 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site

Pismataro, M. C., Horenstein, N. A., Stokes, C. A., Dallanoce, C., Thakur, G. A., & Papke, R. L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174179 · Cited by 8 · see citing works

The prefrontal cortex shows widespread decrease in H3 histamine receptor binding densities in rats with genetic generalized epilepsies

Midzyanovskaya, I. S., Birioukova, L. M., Storvik, M., van Luijtelaar, G., & Tuomisto, L. M. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.106921 · Cited by 7 · see citing works

Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugs

Guandalini, L., Martini, E., Mannelli, L. D. C., Dei, S., Manetti, D., Scapecchi, S., Teodori, E., Ghelardini, C., & Romanelli, M. N. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.045 · Cited by 7 · see citing works

SSR504734 enhances basal expression of prepulse inhibition but exacerbates the disruption of prepulse inhibition by apomorphine

Singer, P., Zhang, W., & Yee, B. K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3160-3 · Cited by 7 · see citing works

Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine by low-dose galantamine in rats

Hahn, B., Reneski, C. H., Lane, M., Elmer, G. I., & Pereira, E. F. R. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173043 · Cited by 6 · see citing works

Design, synthesis and biological evaluation of selected 3-[3-(amino) propoxy] benzenamines as acetylcholinesterase inhibitors

Malik, R., Gupta, R., Srivastava, S., Choudhary, B. S., & Sharma, M. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1220330 · Cited by 6 · see citing works

Predictors for drug effects with brain disease: Shed new light from EEG parameters to brain connectomics

Tian, Y., Li, Y., Xu, W. L., Zhang, H., Wang, Z., Zhang, H., Zheng, S., Shi, Y., & Xu, P. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.04.019 · Cited by 6 · see citing works

Isolation and chemical characterization of agelaiatoxin8 (AvTx8) from Agelaia vicina wasp venom and its biological effects on GABA neurotransmission

Pizzo, A. B., Beleboni, R. O., Carolino, R. O. G., de Oliveira, L. C., Miranda, A., Coutinho‐Netto, J., Fontana, A. C. K., & dos Santos, W. F. (2017) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21941 · Cited by 6 · see citing works

A test of the cognitive-enhancing potential of low-dose mecamylamine in healthy non-smokers

Yuille, M. B., Olmstead, C. K., Wells, A. K., & Hahn, B. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4443-2 · Cited by 5 · see citing works

Introduction to the Special Issue “Pharmacotherapies for the Treatment of Alcohol Abuse and Dependence” and a Summary of Patents Targeting other Neurotransmitter Systems

Bell, R. L., Franklin, K. M., Hauser, S. R., & Zhou, F. (2012) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912800673155 · Cited by 5 · see citing works

Working memory processes and the histamine-3 receptor in schizophrenia: a [11C]MK-8278 PET-fMRI study

Arumuham, A., Shatalina, E., Nour, M. M., Veronese, M., Onwordi, E. C., Kaar, S. J., Jauhar, S., Rabiner, E. A., & Howes, O. D. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06730-6 · Cited by 3 · see citing works

A randomised trial of the effect of the glycine reuptake inhibitor Org 25935 on cognitive performance in healthy male volunteers

Christmas, D. M., Diaper, A., Wilson, S. J., Rich, A. S., Phillips, S. M., de Haes, J. U., Sjögren, M. J. C., & Nutt, D. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2384 · Cited by 4 · see citing works

Standardized Prunella vulgaris var. lilacina Extract Enhances Cognitive Performance in Normal Naive Mice

Park, S. J., Ahn, Y. J., Lee, H. E., Hong, E., & Ryu, J. H. (2015) · Phytotherapy Research · doi:10.1002/ptr.5449 · Cited by 4 · see citing works

Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists

Friedman, J. I. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1794-x · Cited by 183 · see citing works

Cognitive enhancing drugs for schizophrenia

Raedler, T. J. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.10.001 · Cited by 2 · see citing works

Pharmacological Treatment of Cognitive Dysfunction in Neuropsychiatric Disorders

Venero, C. (2015) · Cognitive Enhancement · doi:10.1016/b978-0-12-417042-1.00010-3 · Cited by 4 · see citing works

Treating Schizophrenia: Novel Targets for the Cholinergic System

Money, T., Scarr, E., Udawela, M., Gibbons, A. S., Jeon, W. J., Seo, M. S., & Dean, B. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012062 · Cited by 24 · see citing works

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

Roth, B., Hanizavareh, S. M., & Blum, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1683-8 · Cited by 259 · see citing works